Events
Stay informed on our events
Upcoming Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Previous Events
Digestive Disease Week | May 18th – 21st, 2024
We will be at Digestive Disease Week, Washington, DC, May 18th to 21st, 2024. Don't miss our presentation, titled: “Detection of High-Risk Pancreatic Cysts using Avantect™ blood-based test.”
American Medical Association CPT Editorial Panel Meeting | May 9th – 11th, 2024
The American Medical Association CPT Editorial Panel Meeting took place in Chicago, May 9th to 11th, 2024.
CMS Public Meeting on New and Reconsidered Clinical Diagnostic and Laboratory Test Codes | June 25th, 2024
The CLFS Annual Public Meeting will be held virtually and in-person at the Centers for Medicare & Medicaid Services (CMS), Central Building, 7500 Security Boulevard, Baltimore, Maryland 21244-1850.
American Association for Cancer Research | April, 2024
At the American Association for Cancer Research meeting, April 2024 – we presented a poster titled “Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD1 treatment response and resistance biology in non-small cell lung cancer.”
Precision Med TRI-CON | March, 2024
We attended TRI-CON 2024. If you missed us, contact us to learn about Virtuoso, our epigenomic platform that provides an unprecedented level of clarity to inform cancer diagnosis and treatment. Or, get more information on our presentation! Epigenomic Tools for Early...
European Neuroendocrine Tumor Society | March, 2024
European Neuroendocrine Tumor Society, March 2024 – Oral presentation entitled “ 5-Hydroxymethylcytosine profiling of plasma-derived circulating free DNA in patients with pancreatic neuroendocrine tumors treated with [177Lu]Lu-DOTA-TATE.”
Circulating Nucleic Acids in Plasma Symposium | March, 2024
Circulating Nucleic Acids in Plasma Symposium, March 2024 – Oral presentation entitled “Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD1 treatment response and resistance biology in non-small cell lung cancer.”
PRECEDE – The Pancreatic Cancer Early Detection Consortium | December, 2023
PRECEDE – The Pancreatic Cancer Early Detection Consortium, December 6th, and 7th , 2023
American Pancreatic Association | December, 2023
American Pancreatic Association, December 2023 – Poster presentation “SAFE-D Trial design: Targeted pancreatic cancer screening to evaluate stage and resectability rate shift in patients with new-onset diabetes.”
American Diabetes Association 83rd Scientific Sessions | June, 2023
American Diabetes Association 83rd Scientific Sessions, June 2023 - Poster presentation entitled “Implementation of the Avantect Pancreatic Cancer Test in Newly Diagnosed Type 2 Diabetes Patients in a Clinical Setting.” Meet Us At ADA Booth #1814 ClearNote Health is a...